Table 3.
C-index of Clinical Variables and Biomarkers
| Outcome | Model | Clinical + sTNFR1 + KIM1 | Clinical + sTNFR2 + KIM1 | ||||
|---|---|---|---|---|---|---|---|
| Clinical Alone |
Clinical + sTNFR1 | Clinical + sTNFR2 | Clinical + KIM1 | Clinical + All 3 Markers |
|||
| CKD events | 0.626 | 0.648 (0.0002) | 0.635 (0.13) | 0.644 (< 0.0001) | 0.652 (sTNFR1 0.0004, sTNFR2 0.0135, KIM1 < 0.0001) | 0.656 (sTNFR1 0.0103, KIM1 0.0002) | 0.646 (sTNR2 0.76, KIM1 < 0.0001) |
| CVD | 0.669 | 0.678 (0.0049) | 0.676 (0.0075) | 0.689 (< 0.0001) | 0.692 (sTNFR1 0.42, sTNFR2 0.56, KIM1 0.0015) | 0.692 (sTNFR1 0.09, KIM1 0.0011) | 0.691 (sTNR2 0.11, KIM1 0.0009) |
| Death | 0.667 | 0.685 (< 0.0001) | 0.689 (< 0.0001) | 0.696 (< 0.0001) | 0.703 (sTNFR1 0.32, sTNFR2 0.13, KIM1 < 0.0001) | 0.700 (sTNFR1 0.0028, KIM1 < 0.0001) | 0.704 (sTNR2 0.0014, KIM1 < 0.0001) |
P values for association of biomarker in parentheses
CKD chronic kidney disease, CI confidence interval, CVD cardiovascular disease
Clinical model = Age (per year), recipient gender, white race (Yes/No), non-elective surgery, surgery type, pre-op eGFR, diabetes, hypertension, CHF, history of MI, pre-op urine albumin and urine creatinine, and center